Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 07, 2023

SELL
$203.72 - $248.97 $446,146 - $545,244
-2,190 Reduced 70.87%
900 $211,000
Q3 2022

Nov 10, 2022

SELL
$204.81 - $262.19 $4,096 - $5,243
-20 Reduced 0.64%
3,090 $633,000
Q2 2022

Jul 29, 2022

BUY
$213.86 - $277.87 $109,068 - $141,713
510 Added 19.62%
3,110 $729,000
Q1 2022

May 02, 2022

BUY
$259.82 - $298.18 $675,532 - $775,268
2,600 New
2,600 $686,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.6B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Beck Bode, LLC Portfolio

Follow Beck Bode, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beck Bode, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beck Bode, LLC with notifications on news.